You’re using a public version of DrugPatentWatch with 1 free search available | Register to unlock more free searches. CREATE FREE ACCOUNT

Serving leading biopharmaceutical companies globally:

Last Updated: December 4, 2023

Zydus Pharms Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for ZYDUS PHARMS, and what generic and branded alternatives to ZYDUS PHARMS drugs are available?

ZYDUS PHARMS has two hundred and sixty-five approved drugs.

There are twenty tentative approvals on ZYDUS PHARMS drugs.

Summary for Zydus Pharms

US Patents:	0
Tradenames:	232
Ingredients:	223
NDAs:	265

Drugs and US Patents for Zydus Pharms

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Zydus Pharms	RIVASTIGMINE	rivastigmine	FILM, EXTENDED RELEASE;TRANSDERMAL	206318-002	Mar 4, 2019	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Zydus Pharms	GLYBURIDE AND METFORMIN HYDROCHLORIDE	glyburide; metformin hydrochloride	TABLET;ORAL	206748-002	Feb 29, 2016	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Zydus Pharms	DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE	amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate	TABLET;ORAL	207340-003	Oct 31, 2017	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Zydus Pharms Usa	CLINDAMYCIN HYDROCHLORIDE	clindamycin hydrochloride	CAPSULE;ORAL	065217-002	Jan 31, 2005	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Zydus Pharms	METOPROLOL SUCCINATE	metoprolol succinate	TABLET, EXTENDED RELEASE;ORAL	203894-001	Mar 23, 2018	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Zydus Pharms	MINOCYCLINE HYDROCHLORIDE	minocycline hydrochloride	TABLET, EXTENDED RELEASE;ORAL	203553-008	Nov 16, 2017	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Zydus Pharms	AZELASTINE HYDROCHLORIDE	azelastine hydrochloride	SPRAY, METERED;NASAL	091409-001	Aug 14, 2017	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Paragraph IV (Patent) Challenges for ZYDUS PHARMS drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	for Injection	200 mcg/vial	➤ Subscribe	2015-05-01
➤ Subscribe	for Injection	100 mcg/vial and 500 mcg/vial	➤ Subscribe	2015-04-14
➤ Subscribe	Delayed-release Tablets	20 mg	➤ Subscribe	2015-06-03

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow

Moodys

Boehringer Ingelheim

Colorcon

McKinsey

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.